Antares Pharma, Inc. (ATRS)

Cost of Revenue

$70.60M

TTM · Period ending: · USD

ATRS logo

ATRS Cost of Revenue

Latest reported$70.60M
ATRS TTM Cost of Revenue ($1.04M → $70.60M)
High-resolution chart · PNG

ATRS cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Antares Pharma, Inc. Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
70,603,000
68,281,000
68,373,000
68,461,000
64,498,000
63,100,000
58,067,000
54,612,000
54,576,000
50,475,000
46,079,000
40,306,000
34,825,000
31,065,000
28,541,948
29,775,845
28,432,234
27,466,000
27,048,258
26,559,082
28,260,791
28,816,766
28,102,657
25,168,699
22,558,695
19,457,683
18,905,090
16,312,693
13,734,679
11,236,695
6,498,994
6,996,230
8,346,832
9,197,230
10,214,468
10,506,355
9,556,784
9,520,472
9,962,443
8,473,004
7,335,182
6,797,192
5,535,936
4,808,400
4,411,072
4,273,210
4,985,597
5,118,277
4,742,958
4,139,834
2,981,541
2,365,325
2,279,392
2,019,585
3,437,832
3,393,494
3,426,516
3,442,020
2,070,482
1,838,540
1,702,033
1,555,969
1,333,460
1,313,644
1,150,745
1,136,745
1,234,041
1,199,832
1,334,307
1,372,302
1,408,389
1,684,609
1,850,890
2,007,883
2,091,647
2,424,128
2,414,332
2,573,280
2,864,922
2,363,738
2,230,507
1,846,797
1,493,967
1,464,987
1,602,732
1,646,589
2,115,044
2,070,834
1,707,035
1,785,464
1,552,026
1,652,026
1,852,026
1,852,026
1,821,051
1,621,051
1,521,051
1,321,051
1,236,272
1,236,272
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.